Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies Abstract Hyperhomocysteinemia is recognized as a risk factor for several diseases, including cardiovascular and neurological conditions. Homocysteine (HCys) is a key metabolite involved in the biosynthesis andmetabolismofmethionine (Met),which plays a pivotal role in the physiological cell’s life cycle. The biochemistry of Met is...